FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:812-813 March 13, 1997 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Serge Gauthier. 372 pp., illustrated. Boston, Butterworth–Heinemann, 1996. $125. ISBN 0-7506-9845-4.

Alzheimer's disease is a mass affliction of the elderly. The lifetime risk of dementia is 20 percent; at the age of 90 one of every two people has Alzheimer's disease. Despite the magnitude of the problem, the general diagnostic and therapeutic outlook appears to be nihilistic: because there is no generally accepted treatment, no emphasis is put on a detailed diagnostic workup.

The main message of this book is that there is reason for a measured optimism about the management of Alzheimer's disease. The book reflects the wealth of epidemiologic, clinical, and basic-research findings that have poured out of our . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.